Current State of Neoadjuvant Therapy for Locally Advanced Rectal Cancer
- 1 July 2024
- journal article
- review article
- Published by Wolters Kluwer Health in The Cancer Journal
- Vol. 30 (4) , 227-231
Abstract
In locally advanced rectal cancer, neoadjuvant treatment has evolved from no preoperative treatment to the addition of radiation and systemic therapy and ultimately total neoadjuvant therapy. Total neoadjuvant therapy is the completion of preoperative radiation or chemoradiation and chemotherapy before surgery in order to maximize tumor response and improve survival outcomes. This review summarizes the literature of the neoadjuvant approaches related to locally advanced rectal cancer and highlights the nuances of selecting the appropriate treatment.Keywords
This publication has 47 references indexed in Scilit:
- Risk and location of distant metastases in patients with locally advanced rectal cancer after total neoadjuvant treatment or chemoradiotherapy in the RAPIDO trialEuropean Journal of Cancer, 2023
- Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal CancerJAMA Oncology, 2021
- Use of Total Neoadjuvant Therapy for Locally Advanced Rectal CancerJAMA Oncology, 2021
- Association of Treatment Adherence With Oncologic Outcomes for Patients With Rectal CancerJAMA Oncology, 2020
- Effect of Aflibercept Plus Modified FOLFOX6 Induction Chemotherapy Before Standard Chemoradiotherapy and Surgery in Patients With High-Risk Rectal AdenocarcinomaJAMA Oncology, 2019
- Safety and Feasibility of Using Magnetic Resonance Imaging Criteria to Identify Patients With “Good Prognosis” Rectal Cancer Eligible for Primary SurgeryJAMA Oncology, 2019
- Tumour regression after radiotherapy for rectal cancer – Results from the randomised Stockholm III trialRadiotherapy and Oncology, 2019
- Patterns of local recurrence in rectal cancer; a study of the Dutch TME trialEuropean Journal of Surgical Oncology, 2010
- Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trialThe Lancet, 2009
- Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancerBritish Journal of Surgery, 2006